Experiments for taxon Caralluma retrospiciens (ASCLEPIADACEAE)

Experiments (29 results)

Filters
Worktypes (13)
15
6
5
4
4
4
4
3
3
2
2
1
1
No match
Pharmacology (6)
12
6
2
1
1
7
No match
Compounds (17)
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
18
No match
Organisms (6)
13
7
5
2
1
1
No match
29 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
311466
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Caralluma retrospiciens (ASCLEPIADACEAE)
PREGN-20-ONE,12-BETA-BENZOYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[BETA-D-GLUCOPYRANOSYL(1-6)-BETA-D-GLUCOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSIDE]PREGN-20-ONE,12-BETA-BENZOYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[BETA-D-GLUCOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSIDE]PREGN-20-ONE,12-BETA-BENZOYL-OXY-11-ALPHA-ISO-VALEROYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[BETA-D-GLUCOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE]PREGN-20-ONE,12-BETA-BENZOYL-OXY-11-ALPHA-ISO-VALEROYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[BETA-D-GLUCOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSIDE]PREGN-20-ONE,12-BETA-BENZOYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[BETA-D-GLUCOPYRANOSYL(1-4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE]PREGN-20-ONE,12-BETA-BENZOYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-[3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE]
780712
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
73463
VOUCHER SPECIMEN REPORTED FOR
Caralluma retrospiciens (ASCLEPIADACEAE)
780706
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
1290076
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
12-BETA-BENZOYLOXY-11-ALPHA-ISOVALEROYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL (1-4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAR
780705
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
177045
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caralluma retrospiciens (ASCLEPIADACEAE)
PREGNAN-20-ONE,5-ALPHA: 12-BETA-BENZOYL-OXY-3-BETA-8-BETA-14-BETA-TRIHYDROXY:
780711
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
73467
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CROWN GALL TUMOR INHIBITION
Caralluma retrospiciens (ASCLEPIADACEAE)
1290070
CMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF
Caralluma retrospiciens (ASCLEPIADACEAE)
2-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-6)-BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPY12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSIDE]12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1- 4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE]12-BETA-BENZOYLOXY-11-ALPHA-ISOVALEROYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL (1-4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAR12-BETA-BENZOYLOXY-11-ALPHA-ISOVALEROYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRAN12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE]
780715
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
780704
VOUCHER SPECIMEN REPORTED FOR
Caralluma retrospiciens (ASCLEPIADACEAE)
780709
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
780713
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
73465
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
73466
PHARMACOLOGY OF EXTRACT - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
780710
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
1290071
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE]
780716
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
177046
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caralluma retrospiciens (ASCLEPIADACEAE)
PREGNAN-20-ONE,5-ALPHA: 11-ALPHA-12-BETA-BENZOYL-OXY-ISO-VALEROYL-OXY-3-BETA-8-BETA-14-BETA-TRIHYDROXY:
780708
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
1290075
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
12-BETA-BENZOYLOXY-11-ALPHA-ISOVALEROYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRAN
1290073
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSIDE]
780714
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
187924
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Caralluma retrospiciens (ASCLEPIADACEAE)
PREGN-20-ONE,12-BETA-BENZOYL-OXY-8-BETA-14-BETA-DIHYDROXY: 3-O-(BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDECARETROSIDE A
1290074
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
2-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1-6)-BETA-D-GLUCOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPYRANOSYL-(1-4)-3-O-METHYL-6-DEOXY-BETA-D-GALACTOPY
73464
PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
1290072
PHARMACOLOGY OF COMPOUND - IN VITRO
ANTICRUSTACEAN ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)
12-BETA-BENZOYLOXY-8-BETA,14-BETA-DIHYDROXYPREGN-20-ONE-3-O-[BETA-D-GLUCOPYRANOSYL-(1- 4)-3-O-METHYL-6-DEOXY-BETA-D-ALLOPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE]
780707
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIBACTERIAL ACTIVITY
Caralluma retrospiciens (ASCLEPIADACEAE)